Leadership & Staff
SleepHealth.org is the online home of the Wellness, Sleep and Circadian Network (WSCN), the oldest and largest patient advocacy organization for sleep apnea. We are proud to provide our annual financial information to the public.
Gilles Frydman
Gilles has pioneered online health communities since founding the Association of Cancer Online Resources (ACOR) in 1995. He is a co-founder of Smart Patients and the Society for Participatory Medicine and a former MedicineX Executive Board Member. He strongly believes patients are the most underutilized resource in healthcare. Gilles is a sleep apnea patient with a long-term hypertension history.
Elizabeth Johnson
Elizabeth began her nonprofit accounting career at Suburban Hospital in Bethesda, MD in 2000. Following her career at Suburban Hospital, she worked for a national civil rights advocacy nonprofit organization in Washington, DC, for 11 years, rising to the position of Finance Manager.
Elizabeth joined ASAA in December 2013 as a part-time bookkeeper and became the Finance Manager in 2018. Finding her passion for healthcare again, Elizabeth joined ASAA full-time in June 2020. She is a single mother of three girls, all of which have at least one breathing disorder. She currently lives in Eastern North Carolina.
Valerie Mead
Alice Rolling
Tonia Nordsiden
Erin Taylor
Keyaira Baber
Bookkeeper
Jean-Noel Frydman
Marc K. Garcia
Samantha Black
George Berger
Kristina Blessing
Catherine F. Murray
Board of Directors
Anne Marie Morse
Chairman
Anne Marie Morse is a neurologist with special training in child neurology as well as a sleep medicine specialist. Although an avid educator, successful leader, thoughtful clinician and inquisitive researcher, she views her most important roles in medicine as being a health care partner, advocate and changemaker.
Her proven track record and unwavering commitment to evolve healthcare to a patient directed model that accounts for all hours of the day, considering sleep health and circadian science across all disciplines, is showcased in her development of novel programs like Sleep to Be Well and Wake Up and Learn. Both programs focus on meeting people where they are with information and tools to live most successfully and sleep most restfully. Dr. Morse envisions a world where sleep can be acknowledged as the vital sign of health, wellness, and performance that it is designed to be.
Lynn Grisso
BOARD MEMBER, Interim Treasurer
Lynn Grisco is a healthcare executive and strategic advisor with over two decades of leadership across pharmaceuticals, biotechnology, specialty pharmacy, and patient advocacy. She brings expertise in commercial strategy, patient-centered marketing, and access innovation in CNS, oncology, and rare diseases.
Lynn is the founder & CEO of Grisco Consulting, where she partners with healthcare companies to develop transformative strategies that improve patient outcomes & drive market success. She has held senior leadership roles at Acadia, BMS and Avadel Pharmaceuticals, leading the HCP marketing launch of Lumryz®, a once-nightly treatment for narcolepsy. Her passion for sleep health deepened when her daughter was diagnosed with narcolepsy in 2022, igniting her role as a dedicated caregiver, advocate, and changemaker in the sleep community.
Lynn serves as Vice Chair, BOD for Wake Up Narcolepsy & on the BOD for the Florida Cancer Specialists Foundation to advance person-centered care.
Larissa D’Andrea
Secretary
With over 25 years of experience in the healthcare industry, Larissa is passionate about transforming a system that cares for the sick to one that keeps people well, with the right technology, at the right time. She is person-centric and purpose-driven, engaging in work that drives better health, and has a positive sustainable impact.
Areas of expertise include Environmental, Social, Governance (ESG) corporate strategy, Government Affairs, Market Access, Clinical Advocacy, Patient Advocacy, Medical Affairs strategy, Regulatory Affairs, Quality Assurance, Commercialization of digital solutions, Digital marketing, impact-oriented content production and immersive installations, and Consumer engagement/campaigns to drive behaviors.
She holds BS in Biology from UCSD and a MS in Legal Studies from USD, School of Law. Sleep health is a personal focus with both her father and fiancé managing sleep apnea alongside cardiac conditions. Most recently she held executive roles at ResMed.
Susan Manber
chief patient officer
A rare cancer survivor and patient advocate, Sue is dedicated to ensuring radical patient centricity is at the heart of her role as Chief Patient Officer at Publicis Health, a first in health communications. Sue helped found two start up agencies in the early days of the Internet and DTC communications and has deep health and wellness brand building experience spanning leading companies in virtually every category. She sees sleep as the critically important third pillar of health and is passionate about fueling sleep health for all.
Sue is in demand as a frequent speaker at Healthcare industry conferences and is frequently published, having been featured most recently at HLTH, in Ad Age and honored in the 2020 MM&M Hall of Femme, 2022 Reuters Patient Champion and 2024 HBA Luminary.
John Boyce
BOARD MEMBER
In 2013 John was awarded the honor as one of the top 15 Technology Luminaries in the state of Massachusetts by the Boston Business Journal and Mass High Technology.
John is both a genomics and proteomics serial entrepreneur with seven successful exits, as well as venture capitalist focusing on therapeutics as well as tools and diagnostics, who specializes in building and positioning companies for either acquisition or IPO. He has formed two successful venture capital firms – Tiger Gene, seeded by Tiger Management, as well as 28 Capital, which is a rebrand and expansion of Tiger Gene.
He has successfully raised over $800MM in funding and amassed >$1.8bn through exits. Before co-founding TigerGene Capital, and John’s last exit as a serial entrepreneur, John was President and CEO of Exosome Diagnostics which he drove to a successful acquisition for $575MM to Bio-Techne. John is also a Fellow at Harvard University where he teaches ‘Entrepreneurship and Innovation.’